genXone S.A. (WSE:GX1)
Poland · Delayed Price · Currency is PLN 5.58
-0.06 (-1.06%)
At close: Jul 24, 2026
genXone Market Cap
genXone has a market cap or net worth of 18.44 million as of July 24, 2026. Its market cap has decreased by -3.46% in one year.
Market Cap
18.44M
Enterprise Value
15.38M
Revenue
2.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.58
ChartMarket Cap Chart
Since September 4, 2020, genXone's market cap has decreased from 141.69M to 18.44M, a decrease of -86.98%. That is a compound annual growth rate of -29.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 18.44M | 39.85% |
| Dec 30, 2025 | 13.19M | -35.65% |
| Dec 30, 2024 | 20.49M | 15.53% |
| Dec 29, 2023 | 17.74M | -47.33% |
| Dec 30, 2022 | 33.67M | -51.33% |
| Dec 30, 2021 | 69.20M | 0.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.53B |
| NEUCA | 3.36B |
| Synektik Spólka Akcyjna | 3.07B |
| Voxel | 1.26B |
| Pharmena | 34.64M |
| Airway Medix | 32.46M |
| Medicofarma Biotech | 27.60M |
| Pure Biologics | 26.20M |